Edward M. Md Kaye, CEO: Stoke Therapeutics STOK Sell · Filed 24/12/11

Trade details

Type: Insider sale
Amount: $88,150.14
Shares · price: 6,786 sh · $12.99 a share
Held after: 61,885 sh
Stock: Stoke Therapeutics STOK
Person: Edward M. Md KayeCEO
Trade date: 24/12/09
Filed: 24/12/11
Days to filing: 2 days

Sold 9.9% of holdings

Share of holding sold: 9.9%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/09~25/01/08

Edward M. Md Kaye's recent trades

Edward M. Md KayeDirector
Sell10b5-1 planCytokinetics
Sell10b5-1 plan
Cytokinetics
CYTK
$223.2K
2,933 sh
$223.2K
Filed 06/01
Traded 06/01
Edward M. Md KayeDirector
Planned sale10b5-1 planCytokinetics
Planned sale10b5-1 plan
Cytokinetics
CYTK
$225.1K
2,933 sh
$225.1K
Filed 06/01
Traded 06/01
Edward M. Md KayeDirector
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$269.1K
8,274 sh
$269.1K
Filed 25/12/10
Traded 25/12/08
Edward M. Md KayeDirector
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$120.3K
3,825 sh
$120.3K
Filed 25/12/10
Traded 25/12/08
Edward M. Md KayeDirector
Sell10b5-1 planStoke Therapeutics
Sell10b5-1 plan
Stoke Therapeutics
STOK
$44.1K
1,331 sh
$44.1K
Filed 25/12/10
Traded 25/12/08